Ascendia Pharmaceutical Solutions Expanding Injectable Manufacturing Capabilities in 2024

Jan 31, 2024 12:00:00 AM

Ascendia Pharmaceutical Solutions: Pioneering Pre-Formulation Screenings for Comprehensive Drug Development

Jan 24, 2024 12:00:00 AM

Maximizing Patient Convenience (and Investment) When Bringing Pre-Filled Syringes to Market

Dec 17, 2023 12:00:00 AM

Ascendia Pharmaceutical Solutions Offers Increased Flexibility and Customized Solutions in Spray Drying of Poorly Soluble APIs

Nov 22, 2023 12:00:00 AM

Ascendia Pharmaceutical Solutions Named to Inc. 5000 for Fourth Consecutive Year

Aug 24, 2023 12:00:00 AM

Ascendia Pharmaceutical Solutions Develops Novel Nanoemulsion IV Formulation for Clopidogrel that Received IND Approval

Jul 10, 2023 12:00:00 AM

KCAS and Ascendia Pharmaceutical Solutions: A Perfect Union Of Services

Jun 19, 2023 12:00:00 AM

Ascendia “All-In” on Lipid Nanoparticle Formulations for Your Project Needs

May 24, 2023 12:00:00 AM

Ascendia Pharmaceutical Solutions to Commence Phase III and Commercial Product Manufacturing

Apr 6, 2023 12:00:00 AM

Solubility Screening and Process Scale-up Services from Ascendia

Mar 16, 2023 12:00:00 AM

Ascendia Expands Sterile/Non-Sterile HQ to Nearly 60,000 Square Feet at NJ Bioscience Center in North Brunswick

Mar 13, 2023 12:00:00 AM

Stability Chambers: Testing, Equipment & Uses

Mar 6, 2023 12:00:00 AM